These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4790694)

  • 1. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
    Heppner GH; Stolbach L; Byrne M; Cummings FJ; McDonough E; Calabresi P
    Int J Cancer; 1973 Mar; 11(2):245-60. PubMed ID: 4790694
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
    Hellström I; Warner GA; Hellström KE; Sjögren HO
    Int J Cancer; 1973 Mar; 11(2):280-92. PubMed ID: 4790696
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immune reactions to tumor antigens with particular emphasis on immunity to human neoplasms.
    Hellström I; Hellström KE
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1461-8. PubMed ID: 4417442
    [No Abstract]   [Full Text] [Related]  

  • 4. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
    Cummings FJ; Heppner GH; Stolbach L; Calabresi P
    Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
    [No Abstract]   [Full Text] [Related]  

  • 5. Early onset of serum blocking in a murine melanoma model.
    Bray AE; Holt PG; Roberts LM; Keast D
    Int J Cancer; 1975 Oct; 16(4):607-15. PubMed ID: 1176208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunity to human tumor-associated antigens. A review.
    Herberman RB
    Isr J Med Sci; 1973 Mar; 9(3):300-7. PubMed ID: 4575654
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular and humoral immunity against human malignant melanoma.
    Fossati G; Colnaghi MI; Porta GD; Cascinelli N; Veronesi U
    Int J Cancer; 1971 Sep; 8(2):344-50. PubMed ID: 4943925
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blocking of cellular cytotoxicity by serum factors in progressive malignant melanoma].
    Saal JG; Rieber EP; Hadam M; Riethmüller G; Ehinger H; Wilms K; Wilmanns W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1217-9. PubMed ID: 611821
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro-demonstration of cellular hypersensitivity to tumour antigens in man.
    Andersen V; Kjaer M; Bendixen G
    Ser Haematol; 1972; 5(5):3-21. PubMed ID: 4598039
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system.
    Kumar S; Taylor G; Steward JK; Waghe MA; Morris-Jones P
    Int J Cancer; 1973 Jul; 12(1):194-205. PubMed ID: 4364270
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated and humoral immune reactions to human tumours.
    Baldwin RW; Embleton MJ; Jones JS; Langman MJ
    Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunity to neuroblastomas and melanomas.
    Hellström KE; Hellström I
    Annu Rev Med; 1972; 23():19-38. PubMed ID: 4566479
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responses induced by human malignant melanoma in the rabbit.
    Goodwin DP; Hornung MO; Leong SP; Krementz ET
    Surgery; 1972 Nov; 72(5):737-43. PubMed ID: 4117015
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological studies on malignant melanomas of man.
    Romsdahl MM; Cox IS
    Yale J Biol Med; 1973 Dec; 46(5):693-701. PubMed ID: 4205125
    [No Abstract]   [Full Text] [Related]  

  • 16. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.
    Baldwin RW; Price MR; Robins RA
    Nat New Biol; 1972 Aug; 238(84):185-6. PubMed ID: 4340574
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological studies of women with primary breast carcinoma.
    Jeejeebhoy HF
    Int J Cancer; 1975 Jun; 15(6):867-78. PubMed ID: 1150343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor immunity in melanoma patients as assessed by colony inhibition and microcytotoxicity methods: a preliminary report.
    Byrne M; Heppner G; Stolbach L; Cummings F; McDonough E; Calabresi P
    Natl Cancer Inst Monogr; 1973 Jun; 37():3-8. PubMed ID: 4713784
    [No Abstract]   [Full Text] [Related]  

  • 19. Some recent studies on cellular immunity to human melanomas.
    Hellström I; Hellström KE
    Fed Proc; 1973 Feb; 32(2):156-9. PubMed ID: 4120196
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity.
    Jose DG; Seshadri R
    Int J Cancer; 1974 Jun; 13(6):824-38. PubMed ID: 4136591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.